Clinical trial
Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
NCT00464074
Study timeline
Study start (actual)2007-08-01Date precision: day
Registry last updated2023-08-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Biogenlead sponsor
Elan Pharmaceuticalscollaborator
Mapped research locations
NashvilleTennessee, United States2Salt Lake CityUtah, United States2New YorkNew York, United States1BostonMassachusetts, United States1AtlantaGeorgia, United States1SeattleWashington, United States1PortlandOregon, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1Chapel HillNorth Carolina, United States1LouisvilleKentucky, United States1LexingtonKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00464074 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.